AU1754497A - Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responses - Google Patents
Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responsesInfo
- Publication number
- AU1754497A AU1754497A AU17544/97A AU1754497A AU1754497A AU 1754497 A AU1754497 A AU 1754497A AU 17544/97 A AU17544/97 A AU 17544/97A AU 1754497 A AU1754497 A AU 1754497A AU 1754497 A AU1754497 A AU 1754497A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- transfer
- inflammatory responses
- cells associated
- regulatory genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US997996P | 1996-01-16 | 1996-01-16 | |
US009979 | 1996-01-16 | ||
PCT/US1997/001178 WO1997026325A1 (en) | 1996-01-16 | 1997-01-16 | Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1754497A true AU1754497A (en) | 1997-08-11 |
Family
ID=21740818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17544/97A Abandoned AU1754497A (en) | 1996-01-16 | 1997-01-16 | Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responses |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1754497A (en) |
WO (1) | WO1997026325A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1015003A1 (en) * | 1997-09-19 | 2000-07-05 | Johnson & Johnson Research Pty Ltd. | Transgenic autologous t-cell therapy in humans, and related compositions and kits |
DE10164819A1 (en) | 2001-11-20 | 2005-05-19 | Deml, Ludwig, Dr. | Method for identifying target epitopes of the T-cell-mediated immune response and for detecting epitope-specific T cells |
DE10156863B4 (en) * | 2001-11-20 | 2004-06-09 | Deml, Ludwig, Dr. | Method for the identification of target epitopes of the T cell-mediated immune response and for the detection of epitope-specific T cells |
WO2009108341A1 (en) | 2008-02-28 | 2009-09-03 | Argos Therapeutics, Inc. | Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
-
1997
- 1997-01-16 WO PCT/US1997/001178 patent/WO1997026325A1/en active Application Filing
- 1997-01-16 AU AU17544/97A patent/AU1754497A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997026325A1 (en) | 1997-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6724598A (en) | 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteinsinhibitors | |
AU7442398A (en) | Glucosamine fatty acid compositions and their use | |
HUP0001120A2 (en) | Vectors and methods for gene transfer to cells | |
AU9582398A (en) | Methods and devices for the long-term culture of hematopoietic progenitor cells | |
AU4065397A (en) | Stable compositions for nucleic acid amplification and sequencing | |
AU3740197A (en) | Chondrocyte media formulations and culture procedures | |
AU6178296A (en) | Heat cells | |
AU9774998A (en) | Method for gene transfer using bcl2 and compositions useful therein | |
AU1265197A (en) | Target cell-specific vectors for inserting genes into cells, pharmaceuticals comprising such vectors and their use | |
AU4421897A (en) | Compositions and insulation bodies having low thermal conductivity | |
AU3882997A (en) | Human telomerase gene | |
AU7571898A (en) | Equalization of series-connected cells and batteries | |
AU6229498A (en) | Composition for gene introduction into cell | |
AU2001285314A1 (en) | Methanotrophic carbon metabolism pathway genes and enzymes | |
AU3633199A (en) | Methionin containing animal cell culture medium and its use | |
IL136826A0 (en) | Essential bacterial genes and their use | |
AU7476198A (en) | Cell proliferation related genes | |
AU1698197A (en) | Glutenin genes and their uses | |
AU2682895A (en) | EG Cells of Ungulates | |
AU1754497A (en) | Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responses | |
AU2362795A (en) | Introduction of HIV-protective genes into cells by particle-mediated gene transfer | |
AU8505898A (en) | Nucleic acid compositions and methods of introducing nucleic acids into cells | |
AU4573396A (en) | Use of krill enzymes in feedstuff | |
AU4156697A (en) | Long-term expression of gene products by transforming muscle cells | |
AU3734997A (en) | Bacterial sucrose synthase compositions and methods of use |